SnakeBite911 vs STAT EM
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SnakeBite911
This app provides emergency guidance for snakebite incidents, including immediate steps, identification of North American venomous snakes, and a tool to track venom spread. It offers offline functionality and quick access to emergency services.
- Emergency snakebite support
- Quick dial 911
- Actionable do's and don'ts
- Venom Tracker photo tool
- North American venomous snake identification
- Safety and avoidance tips
- Offline functionality
Read full descriptionHide full description
*New app! This new SnakeBite911 consolidates an older suite of apps (SnakeBite911ER, SnakeBite911FR and SnakeBite911) into one tool. It features a refreshed design and a new emergency mode for quick access to core functionality.* This useful guide can help educate you about North American venomous pit viper snakes (including rattlesnakes, copperheads and cottonmouths), how to best avoid them, and what to do and what NOT to do should a snake strike happen! This app also works without signal. Features • Emergency support for snakebite emergencies • Quick dial 911 • List of actions you should/shouldn’t take in supporting the snakebite victim • Venom Tracker photo tool to log the spread of venom, which can help save diagnostic and treatment time when the victim gets to the ER • Learn about North American venomous snakes and how to identify them • Learn how to keep safe from snakes and avoid being bitten The new SnakeBite911 app comes from the manufacturers of CroFab® CrotalidaePolyvalent Immune Fab (Ovine), a sheep-derived antivenin indicated for the management of adult and pediatric patients with North American crotalid envenomation. The term crotalid is used to describe the Crotalinae subfamily (formerly known as Crotalidae) of venomous snakes which includes rattlesnakes, copperheads and cottonmouths/water moccasins. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Do not administer CroFab® to patients with a known hypersensitivity to any of its components, or to papaya or papain unless the benefits outweigh the risks and appropriate management for anaphylactic reactions is readily available. WARNINGS AND PRECAUTIONS Coagulopathy: In clinical trials, recurrent coagulopathy (the return of a coagulation abnormality after it has been successfully treated with antivenin), characterized by decreased fibrinogen, decreased platelets, and elevated prothrombin time, occurred in approximately half of the patients studied; one patient required re-hospitalization and additional antivenin administration. Recurrent coagulopathy may persist for 1 to 2 weeks or more. Patients who experience coagulopathy due to snakebite should be monitored for recurrent coagulopathy for up to 1 week or longer. During this period, the physician should carefully assess the need for re-treatment with CroFab® and use of any type of anticoagulant or anti-platelet drug. Hypersensitivity Reactions: Severe hypersensitivity reactions may occur with CroFab®. In case of acute hypersensitivity reactions, including anaphylaxis and anaphylactoid reactions, discontinue infusion and institute appropriate emergency treatment. Patients allergic to papain, chymopapain, other papaya extracts, or the pineapple enzyme bromelain may also have an allergic reaction to CroFab®. Follow-up all patients for signs and symptoms of delayed allergic reactions or serum sickness (e.g., rash, fever, myalgia, arthralgia). ADVERSE REACTIONS The most common adverse reactions (incidence ≥ 5% of subjects) reported in the clinical studies were urticaria, rash, nausea, pruritus and back pain. Adverse reactions involving the skin and appendages (primarily rash, urticaria, and pruritus) were reported in 12 of the 42 patients. Two patients had a severe allergic reaction (severe hives and a severe rash and pruritus) following treatment and one patient discontinued CroFab® due to an allergic reaction. Recurrent coagulopathy due to envenomation and requiring additional treatment may occur. Find out more at www.CroFab.com, which includes the full Prescribing Information. To report suspected adverse reactions, contact 1-877-377-3784 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
STAT EM
This medical app provides medication calculations for patients from neonates to adults, featuring updated evidence-based algorithms and emergency medication dosing. It includes pediatric oral antibiotic guidelines, neonatal resuscitation management, and an augmented reality feature for weight estimation. Future updates will allow users to save favorite content.
- Medication calculations (neonates to adults)
- Pediatric oral antibiotic guidelines
- Updated evidence-based algorithms
- Neonatal resuscitation management
- Adult emergency medication calculations
- AR weight estimation feature
Read full descriptionHide full description
We’re excited to offer STAT EM, an enhanced version of Pedi STAT, providing medication calculations for neonates to adults. To keep giving you the most up to date content, we’ve moved to a subscription model to keep our app free of advertising. This new version contains pediatric oral antibiotic guidelines and dosing, updated evidence-based algorithms, and neonatal resuscitation management. It also includes adult emergency medication calculations including both weight-based and fixed dosing volumes. We’ve added an AR feature allowing you to use your device to measure the length of child to assist in weight estimations. Finally, you will soon have the ability to save favorites to assist you in finding the content you use most frequently. Terms of use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Screenshots
Verdict
The clearest difference is rating: STAT EM at 4.1 against SnakeBite911's 3.3. STAT EM also leads on review sentiment (33% vs 20%) and chart position (#155 vs unranked). SnakeBite911's advantage is in-app purchases (none vs 2) and iOS requirement (13.0 vs 15.0). On price, ratings volume, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. STAT EM sells 2 in-app purchases, starting at $0.99 per month. SnakeBite911 asks for nothing beyond the download.
STAT EM holds the better App Store score, 4.1 against 3.3. Both are backed by a comparable volume of ratings — 18 and 9 respectively. Written reviews point the same way: 20% of SnakeBite911's written reviews are positive against 33% of STAT EM's.
SnakeBite911 ships an update every 3 months, STAT EM every 6 weeks. The most recent releases landed on September 26, 2026 and October 8, 2026 respectively.
| Parameter | SnakeBite911 | STAT EM |
|---|---|---|
| Price | Free | Free |
| Rating | 3.3 (18 ratings) | 4.1 (9 ratings) — better |
| Positive reviews | 20.0% of reviews | 33.3% of reviews — better |
| Number of ratings | 18 — better | 9 |
| Update frequency | Every 3 months | Every 6 weeks — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Subscription |
| Best chart rank | — | #155 — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 159 MB | 34 MB |
| Age rating | 17+ | 17+ |
| Developer | BTG plc | James M Kempema MD PA |
Customer experience
SnakeBite911
STAT EM
In-app purchases
SnakeBite911
No in-app purchases
STAT EM
- STAT EM Monthly$0.991 Month
- STAT EM Annual$7.991 Year









